ProfileGDS5822 / ILMN_1246471
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 68% 71% 70% 65% 72% 67% 68% 65% 68% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 14468
GSM1276600PDAC Late Ablation Control 261.271
GSM1276601PDAC Late Ablation Control 371.570
GSM1276602PDAC Late Ablation 132.665
GSM1276603PDAC Late Ablation 26872
GSM1276604PDAC Late Ablation 347.467
GSM1303940PDAC Late Ablation_anti-CTLA4 140.968
GSM1303941PDAC Late Ablation_anti-CTLA4 245.965
GSM1303942PDAC Late Ablation_anti-CTLA4 360.168